DocWire News Editors

DocwireNews

Patients with type 2 diabetes can experience comorbidities that lead to hospitalizations and impact the economic disease burden.Researchers sought to estimate incremental all-cause healthcare resource utilization and costs among patients with type 2 diabetes experiencing cardiovascular-, heart failure-, or renal-related hospitalizations and compare them with patients with diabetes without these complications. The results of the study were presented at the AMCP Annual Meeting during a poster session titled &ldquo;Healthcare Resource Utilization and Costs Among Patients with Cardiovascular, Heart Failure, or Renal-Related Hospitalizations and Type 2 Diabetes.&rdquo;This retrospective study used the Humana claims database to identify patients 18 to 90 years with cardiovascular, heart failure, or renal hospitalizations from October 1, 2009, to September 30, 2015. Eligible patients had 12 months of continuous enrollment prior to the date of first hospitalization and were followed for up to 12 months. A diagnosis of type 2 diabetes was required during the pre-index period.They identified a total of 221,229 patients with cardiovascular events, 68,126 with heart failure events, and 120,105 patients with renal events. These patients had significantly higher mean ages and Deyo Charlson comorbidity scores compared with the cohort without these comorbidities.After adjusting for baseline covariates, the researchers found that patients in the comorbidities cohort (cardiovascular, heart failure, and renal cohort) had significantly higher mean inpatient stays (0.10 vs 0.01; 0.17 vs 0.03; 0.14 vs 0.02), outpatient visits (1.44 vs 0.82; 1.73 vs 1.00; 1.61 vs 0.93), and emergency room visits (0.17 vs 0.02; 0.25 vs 0.04; 0.21 vs 0.03) per-patient, per-month (PPPM) compared with the patients without comorbidities.Adjusted mean PPPM costs were significantly higher in the cardiovascular ($2,686), heart failure ($4,111), and renal cohorts ($3,703) compared with those without cardiovascular ($510), heart failure ($930), or renal ($774) comorbidities.&ldquo;The findings might be helpful for providers in developing approaches to advance value-based healthcare in this population,&rdquo; the researchers concluded.The study was sponsored by Boehringer Ingelheim and Humana.Annavarapu S, Ghosh S, Li Y, Moretz C, Shetty S, Prewitt T. Healthcare Resource Utilization and Costs Among Patients with Cardiovascular, Heart Failure, or Renal-Related Hospitalizations and Type 2 Diabetes. Abstract E14. Presented at the AMCP Managed Care &amp; Specialty Pharmacy Annual Meeting, April 23-26; Boston, MA.

Areef Ishani, MD

Joel M. Topf, MD, FACP

Kidney Stones With Chlorthalidone Versus Hydrochlorothiazide

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Seldin Award Winner Advocates Online Education

Latest News

Economic Burden is Higher for Patients with Type 2 Diabetes and Comorbidities

AMCP 2018

Patients with type 2 diabetes can experience comorbidities that lead to hospitalizations and impact the economic disease burden. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe